{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-038316","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.158439+00:00","generated_at":"2026-05-24T21:33:42.849405+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aveanna Q4 2024 revenue $519.9M (+8.6%), net income $29.2M vs loss; Adj. EBITDA +42.8%; FY2025 guidance","bullets":["Q4 revenue $519.9M (+8.6% YoY); gross margin $171.7M (33.0%) up 15.7%.","Q4 net income $29.2M vs net loss $25.7M; diluted EPS $0.14 vs ($0.13).","Q4 adjusted net income $11.1M (+$14.3M); adjusted diluted EPS $0.05 vs ($0.02).","Q4 Adjusted EBITDA $55.2M (+42.8%); FY2024 revenue >$2B, Adj. EBITDA >$183M.","FY2025 guidance: revenue $2.10–$2.12B; Adj. EBITDA $190–$194M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-038316","json":"https://secwatch.observer/filing/0000950170-25-038316.json","markdown":"https://secwatch.observer/filing/0000950170-25-038316.md","text":"https://secwatch.observer/filing/0000950170-25-038316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000095017025038316/0000950170-25-038316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000095017025038316/avah-20250313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:33:42.849405+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}